< Return To Firm Directory


London, UK

Citeline, known for its comprehensive business intelligence offerings, primarily serves the health science sector. It emerged from its former identity, Pharma Intelligence, following Warburg Pincus’ acquisition from Informa PLC. This transition marked Citeline’s evolution into an independent entity, emphasizing its commitment to offering high-quality products and services in pharmaceutical and biotech industries. The rebranding reflects Citeline’s focus on the global future of pharmaceutical and biopharmaceutical research, underlining its mission to connect treatments to patients and vice versa.

Citeline’s product suite, highly regarded in the clinical trial intelligence space, provides insights on patient enrollment and demographics, trial progress, and more for over 375,000 clinical trials across 180 countries. This information is crucial for driving clinical, commercial, and regulatory decisions, thereby creating opportunities for growth in the health sciences domain. The company’s mission statement encapsulates its focus on research and its impact on patient outcomes, emphasizing the role of a curious mind in uncovering the best evidence for treatments.

In November 2022, Citeline completed a merger with Norstella, forming a $5 billion global pharmaceutical technology company. This merger brought together several prominent organizations, including Citeline, to offer a full range of pharmaceutical consultancy services and solutions. The combined entity aims to guide life sciences companies through the entire drug development process, ensuring quicker patient access to therapies. Norstella’s solutions, enriched by the merger, empower stakeholders to identify unmet clinical needs, construct informed clinical trials, and accurately identify patients for these trials. This union also emphasizes Citeline’s commitment to innovation and accessibility in healthcare.

Overall, Citeline, with its suite of business intelligence offerings and its role in the recent merger with Norstella, stands as a significant entity in the health science world, playing a vital role in connecting treatments with patients and driving important decisions in the pharmaceutical, biomedical, and medtech industries.


  • London Area
North America
  • Boston
Citeline Salary
Undergraduate/Master’s Consultant Salary
  • Base: $90,000
  • Total Cash: up to $90,000
  • PTO Vacation: 20 days
  • Retirement: 3% match